Stuart Thomas, MD
Plastic Surgery within the Head & Neck · Arlington, TXNPI 1639125529
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations.
Across 111 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$433
- Optinose US, Inc.$316
- Kaleo, Inc.$259
- Sanofi-aventis U.S. LLC$175
- Regeneron Healthcare Solutions, Inc.$150
- Cumberland Pharmaceuticals, Inc.$112
- plus $768 from 19 others
What the payments were for
- Food & beverage$2,213100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 18 | $433 |
| Optinose US, Inc. | 16 | $316 |
| Kaleo, Inc. | 19 | $259 |
| Sanofi-aventis U.S. LLC | 9 | $175 |
| Regeneron Healthcare Solutions, Inc. | 6 | $150 |
| Cumberland Pharmaceuticals, Inc. | 8 | $112 |
| Medtronic | 4 | $104 |
| Stryker | 4 | $86 |
| Arrinex, Inc. | 1 | $76 |
| Alk-abello, Inc | 4 | $73 |
| Smith+Nephew | 3 | $58 |
| GSK | 3 | $48 |
| KARL Storz Endoscopy-america | 1 | $47 |
| AstraZeneca | 2 | $41 |
| Olympus America Inc. | 2 | $31 |
| Merck | 2 | $29 |
| Acclarent, Inc | 1 | $29 |
| Photonicare Inc | 1 | $24 |
| Aerin Medical Inc. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Pfizer | 1 | $19 |
| Amgen | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Xoran Technologies LLC | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $12 |
How this compares
$2,213 in reported general payments places this provider in the 55th percentile of 50 plastic surgery within the head & neck providers in Texas.
See all plastic surgery within the head & neck providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 19 | $2,277 |
| Fluocinolone Acetonide Oil | 36 | $1,609 |
| Ipratropium Bromide | 57 | $1,281 |
| Pantoprazole Sodium | 107 | $596 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $357 |
| Acetic Acid | 17 | $307 |
| Prednisone | 79 | $184 |
| Levofloxacin | 18 | $124 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $116 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery within the head & neck in Arlington
- Phillip BrownArlington$29
- Sean BoutrosHouston$335K
- Baran SumerDallas$91K
- Anthony BrissettHouston$25K
- Jack HuaRichmond$25K
- Frank GlatzMcAllen$23K
- Sarah FrommerAustin$7K
- Wilbur HahOrange$7K
- Viran RanasingheLeague City$6K
- Felix Maldonado ChapaLeague City$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.